Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Hospital
about
Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast CancerUnderstanding the Precision in "Precision Medicine"PRECISION ONCOLOGY DECISION SUPPORT: CURRENT APPROACHES AND STRATEGIES FOR THE FUTURE.Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm
P2860
Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Hospital
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metastatic Breast Cancer With ...... Massachusetts General Hospital
@en
Metastatic Breast Cancer With ...... lecular and Precision Medicine
@nl
type
label
Metastatic Breast Cancer With ...... Massachusetts General Hospital
@en
Metastatic Breast Cancer With ...... lecular and Precision Medicine
@nl
prefLabel
Metastatic Breast Cancer With ...... Massachusetts General Hospital
@en
Metastatic Breast Cancer With ...... lecular and Precision Medicine
@nl
P2093
P2860
P1433
P1476
Metastatic Breast Cancer With ...... Massachusetts General Hospital
@en
P2093
Aditya Bardia
Jerry Younger
John A Iafrate
Tilak Sundaresan
Valentina Nardi
P2860
P304
P356
10.1634/THEONCOLOGIST.2016-0240
P577
2016-08-22T00:00:00Z